Amazon S3 on MSN
WHO supports weight loss drugs for tackling obesity crisis
Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...
Novo, however, vastly underestimated the appetite for its new weight-loss jab. Mr Doustdar says it planned for demand to be three times that of Saxenda, an older and less-effective weight-loss drug.
The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...
A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...
Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective ...
Scientists have discovered that semaglutide, the active ingredient in drugs like Ozempic and Wegovy, offers a new benefit for ...
PICKING up her phone, Oonagh Van der Berg goes to read a WhatsApp message – but the 45-year-old, from Belfast, can’t focus.
While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...
Ask any woman (and a lot of men) what their ultimate beauty goal is and their answer would be simple: A crowning glory of ...
Pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations, ...
Amy Schumer's jaw-dropping divorce reveal has fans shook! Find out how the comedian dropped the bombshell in a way that only ...
The past 18 months have been absolutely terrible for Novo Nordisk (NYSE: NVO). The Denmark-based drugmaker has faced poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results